INTRODUCTION
Wilson's disease (WD) is an autosomal recessive disorder with a copper metabolism defect, including deficient incorporation of copper into ceruloplasmin and impaired biliary copper excretion. The metabolism lesions lead to toxic accumulation of copper in various tissues, principally the liver and brain, which can cause complex clinical manifestation, such as hepatic, neurological or psychiatric impairment and Kayser-Fleischer (K-F) ring. The worldwide prevalence of WD is estimated to be 1 in 30 000, with a corresponding gene frequency of 0.56% and a carrier frequency of B1 in 90. 1 Early diagnosis and treatment are essential in decreasing morbidity and mortality because WD is lethal if untreated. 2 WD is caused by mutations of the ATP7B gene, which maps at chromosome 13q14.3 and encodes a copper-transporting P-type ATPase. This protein is composed of 1465 amino-acid residues that form 6 copper-binding domains, 8 transmembrane domains, the phosphatase domain TGEA, the phosphorylation domain DKTGT, the ATP-binding domain TGDN and the MxGDGxNDxP domain, which connects the ATP-binding domain to the transmembrane segment. 3 Mutation analysis has been investigated in many WD patients in different ethnic populations and 4500 different ATP7B mutations have been identified (http://www.wilsondisease.med. ualberta.ca/database.asp). 4 More than 100 of these mutations have been identified in Chinese populations. p.Arg778Leu in exon 8 was the first hot point mutation found in China. 5, 6 There are few reports of mutations of the ATP7B gene and the genotype-phenotype correlation in southern Chinese patients.
Here, we examined the genotypes of the ATP7B mutant alleles in 73 WD patients using denaturing high-performance liquid chromatography (DHPLC) 7, 8 and DNA sequencing. A total of 38 different mutations were identified and 10 of these are novel. The characteristics of the mutations were compared with the clinical symptoms to find the genotype-phenotype correlation in southern Chinese WD patients.
MATERIALS AND METHODS Subjects
A total of 73 WD patients (41 males and 32 females including 2 affected siblings, onset age was from 3 to 48 years) from 70 unrelated families of ethnic Han Chinese originating from Guangdong and Guangxi provinces were enrolled in this study. The diagnosis of WD was based primarily on clinical symptoms including the presence of K-F ring in the cornea, acute or chronic liver failure and/or typical neurological symptoms, and on biochemical parameters including low serum ceruloplasmin (o0.2 g l -1 ) and high-level excretion of urinary copper (4100 mg per 24 h). 9 A total of 200 healthy Chinese individuals were enrolled as a control group. Informed, written consent was obtained from all patients and controls for participation in this study.
Genomic DNA preparation and PCR of the ATP7B gene Genomic DNA was extracted from peripheral blood using the standard phenol/ chloroform extraction procedure. All the coding exons of ATP7B and their associated splice-site junctions were amplified by the PCR using published primers 7, 10 or newly designed primers ( 
Statistical analysis
Data were analyzed using the SPSS statistical package (version 8; SPSS, Chicago, IL, USA) and the results are presented as mean ± s.d. Statistical analysis was done using Student's t-test or the w 2 test. The level of statistical significance was set at Pp0.05.
RESULTS
Analysis of mutation and polymorphism in the ATP7B gene We investigated 73 patients (146 chromosomes) with WD from 70 families, and identified 38 different ATP7B mutations that included 24 missense mutations, 3 splice-site mutations, 5 nonsense mutations and 6 frameshift mutations (Table 2 ). In all, five mutations were identified on exon 8 or 12, four on exon 16, three on exons 3, 7, 11 or 13, whereas none was found on exons 1, 4, 5, 9, 20 or 21. c.2333G4T (p.Arg778Leu) is a common mutation in the Chinese population and it was the most common mutation in this study. It was detected in 32 patients (2 homozygous, 16 compound heterozygous and 14 single heterozygotes) and accounted for 23.29% of the alleles studied. The second most frequent mutation was c.3443T4C (p.Ile1148Thr), which accounted for 9.59% of the alleles studied.
In addition to the mutations, 13 polymorphisms were identified, and details of them are given in Table 3 . These base substitutions were defined as polymorphisms because they either did not modify the amino-acid sequence or led to conservative changes in the amino-acid residues or existed in healthy chromosomes. Among the 13 polymorphisms, 11 were found in the present study and 2 of them are novel. The novel polymorphisms c.1839C4T (p.Ile613Ile) and c.2922G4A (p.Thr974Thr) are synonymous and, although they were not detected in the 200 healthy controls, we still consider them to be polymorphisms.
Evaluation of the genotype-phenotype correlation
Mutations in ATP7B were identified in 69 of the 73 patients (3 homozygotes, 30 compound heterozygotes and 36 single heterozygotes) and no mutation was detected in 4 patients. The mutation detection rate was 69.86% (102 disease alleles found in 146 chromosomes). The mean age of patients at disease manifestation was 15.10 ± 9.01 years. Of the 73 patients, 45 had a primary hepatic manifestation, 27 showed a primary neurological and psychiatric manifestation and 1 had combined hepatic and neurological manifestation.
Evaluation of the genotype-phenotype correlation was possible only in the 33 patients who were found to carry at least two mutations (the clinical features and molecular basis are shown in Supplementary  Table 1 ). Two homozygotes of p.Arg778Leu and one homozygote with p.Arg919Gly were identified. The age of onset and status of K-F ring were similar among these three homozygotes. However, one homozygote of p.Arg778Leu displayed symptoms in the liver and the other displayed symptoms in the brain.
Interestingly, we found that a pair of siblings carried the same genotype but were different clinical type (Figure 1a) . The proband was a 19-year-old female who displayed WD neurological and psychiatric type with serum ceruloplasmin 0.08 g l -1 ; she was 13 years old at onset and was diagnosed at 16 years of age. She was a compound heterozygote of c.314C4A mutation (inherited from her father) and c.3443T4C mutation (inherited from her mother). Her younger brother had no significant clinical symptom of WD except K-F ring. According to the family history of WD and WD-related checkup, he was diagnosed as WD hepatic type at 12 years of age with serum ceruloplasmin of 0.08 g l -1 and abnormal aminotransferase (alanine aminotransferase was 68 U l -1 , aspartate aminotransferase was 58 U l -1 ) and his genotype was the same as that of his sister. Both patients were treated with sodium 2,3-dimercapto-1-sulfonate and their symptoms were improved.
In addition, two patients were found to have three mutations (Figure 1b) . They carried both c.3443T4C and c.3426G4C on the same allele and another mutation, c.2924C4A or c.2333G4A, on the other allele. The parental genotypes of one patient confirmed that c.3426G4C cosegregated in cis with c.3443T4C and the compound heterozygosity on the same chromosomes. Both patients were diagnosed as WD neurological and psychiatric type with low serum ceruloplasmin (one was 0.08 g l -1 and the other was 0.09 g l -1 ). One male patient was first diagnosed at 13 years of age and the main clinical manifestations were clumsiness, tremor and voice vague with no apparent cause. The other male patient was first diagnosed at 37 years of age and the main symptom was tremor, which became more serious, and 1 year ago he presented with fatigue and anorexia. Both c.3443T4C and c.3426G4C were described as disease-causing mutations by Loudianos et al. 11, 12 Neither of these mutations was found in the 200 healthy control subjects.
Identification of 10 novel ATP7B mutations
In this study, 10 novel mutations were found, including 6 missense mutations (c.2120A4G, c.2564C4A, c.2620G4C, c.2761A4C, c.3236G4T and c.3446G4A), 2 splice-site mutations (2121+3A4T and 3244-2A4G), 1 nonsense mutation (c.3682A4T) and 1 frameshift mutation (1875_1876insAATT). The results of sequencing and DHPLC analysis of the novel mutations are shown in Figure 2 . Among these novel mutations, c.3446G4A and 3244-2A4G were detected on two alleles and the others were found on one allele only. None of the novel mutations was found in the 200 healthy controls. These mutations were identified as novel to the WND database (http://www.wilsondisease.med.ualberta.ca/database.asp).
DISCUSSION
WD is a lethal genetic disorder if untreated, and early diagnosis of asymptomatic individuals is extremely important. In this study, 73 individuals affected with WD were analyzed by DHPLC and direct sequencing of the exon sequences of the ATP7B gene. In all, 38 mutations were detected and 10 of these are novel. The novel mutations included 6 missense, 2 splice-site, 1 nonsense and 1 frameshift. They were classified as disease-causing mutations and none was found in the 200 healthy controls. According to our data, a missense mutation is the most frequent type in southern Chinese patients; 102 WD chromosomes were detected among a total of 146 alleles. In 36 patients, only 1 mutation was found, suggesting that the other unknown mutation might be located on the outside exons and the flanking regions, such as the promoter, introns or other DNA control regions. The p.Arg778Leu mutation was the most frequent in our patients, accounting for 23.29% of alleles studied. It is the most prevalent mutation in other Chinese populations, such as eastern Chinese (50%) 13 and Taiwanese (27%). 14 It is also the most common mutation in Asian populations, including Korean (37.9%), 15 Japanese (13.4%) 16 and Thai (10.52%). 17 The second most frequent mutation was p.Ile1148Thr (9.59%) in exon 16, but the other hot mutation, p.Thr935Met in exon 12, was detected in only one allele, which differs from the published results of earlier research. 18 The p.His1069Gln mutation is the most common mutation in European populations, [19] [20] [21] but it was not found in our patients. All other mutations were identified at a low frequency. Only 3 among 73 patients were homozygotes, indicating that the ATP7B mutation is characteristic of a compound heterozygous mutation and a rare homozygous mutation.
The mean onset age of 73 patients was 15.10 ± 9.01 years. More patients displayed a hepatic manifestation than those who displayed a neurological manifestation (45 vs 27). K-F ring was observed in 66 patients; the detection rate was 90.41%. Seven patients without K-F ring were diagnosed in early childhood with abnormal aminotransferase. We observed three especially interesting cases. In case 1, a pair of siblings carried the same genotype but different clinical types, which suggested that the genotype-phenotype correlation of WD had great genetic heterogeneity and there might be other factors that affect the phenotype, which needs further study. In cases 2 and 3, both patients carried three mutations and had been diagnosed as neurological and psychiatric type WD. We found that c.3426G4C cosegregated in cis with c.3443T4C and the parental genotypes confirmed compound heterozygosity of c.3426G4C and c.3443T4C on the same chromosomes. This phenomenon had been described only in WD patients in Hong Kong Chinese, 22 which suggested that this cis-mutation might be specific for southern Chinese WD patients.
Evaluation of the genotype-phenotype correlation was done with 33 homozygotes and compound heterozygotes (Supplementary Table  1 ). Patients with only one detected mutant allele were excluded. It is difficult to investigate the potential correlation between genotypes and phenotypes because many different mutations are detected and most patients are compound heterozygotes with different genotypes. We therefore restricted our investigation to a comparison between p.Arg778Leu homozygosity and compound heterozygosity with the clinical data (Supplementary Table 2 ). No significant difference was found in the levels of serum copper or ceruloplasmin in these two groups. We observed that the average onset age in compound heterozygotes was significantly earlier (P¼0.002) than that in the homozygotes, which is in contradiction to the findings reported by Ye et al. 13 and Wu et al. 23 This difference might be because the patient groups in the different studies were from different geographic areas of China and there are only two homozygotes in the present study.
In conclusion, we had identified 10 novel mutations. It expanded the range of mutations in Chinese population and enriched the mutation spectrum of the ATP7B gene worldwide. We also found several interesting cases that could provide valuable information for genetic counseling and clinical/prenatal diagnosis to prevent WD in China. According to our study, the genetic background of WD has great heterogeneity, and we can not speculate the phenotype by genotype. Other factors that affected the phenotype need further study.
